Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Calgary

$80,000.00

Regulation of brain oxygenation

EF 2024-25

Résumé
My long term research program aims to determine how oxygen levels in brain are regulated, how the brain adapts to low oxygen (hypoxia) and how hypoxia impacts brain physiology and function. We developed implantable probes to quantify oxygen tension. We showed oxygen declines linearly with inspired oxygen, until a plateau is reached, corresponding to oxygen delivery limitations. We developed a near-infrared (NIRS)/MRI protocol to quantify hypoxia, perfusion and metabolic rate for oxygen (CMRO2) in rodent cortex. We showed that inflammation can cause hypoxia in the brain. As an inflammatory response is ubiquitous in vertebrates, and hypoxia is associated with impaired brain function, there must be a strong adaptive benefit of having hypoxia occur in conjunction with inflammation. This led to the current proposal. We will build on these observations and include technical developments to study the physiological and metabolic changes that occur in brain during inflammation induced hypoxia, and how hypoxia impacts the immune response in brain. In Aim 1 we will develop new NIRS processing that will allow us to extract data on cytochrome oxidase (COO), a mitochondrial enzyme key to using oxygen. We will assess different spectral regions and validate with hypoxia and a mitochondrial inhibitor. The improved capability to assess COO will allow us to quantify mitochondrial redox-a marker of mitochondrial function. In Aim 2 we will characterize the temporal and spatial pattern of inflammation related hypoxia in brain. We will combine NIRS, implanted probes, and histology to study hypoxia induced by inflammation (lipopolysaccharide). In Aim 3 we will test the hypothesis that such inflammation induced hypoxia is associated with mitochondrial impairment, reduced metabolic rate and reduced perfusion. We will quantify arterial saturation, perfusion with 9.4T MRI arterial spin labelling, microvascular hemoglobin saturation with NIRS and CMRO2. COO will be assessed with NIRS, stains for COO and mitochondrial respiration studies. We will quantify hypoxia inducible factor (HIF1-a) and a marker of inflammation (NfkB). We hypothesize that hypoxia can cause a feedback loop to further stimulate inflammation. In Aim 4 we will stimulate inflammation in the presence of acute inspired hypoxia. Animals will be exposed to ½ atmosphere hypobaric hypoxia, and inflammation will be induced by exposure to LPS. We hypothesize that inflammatory markers and physiological responses will be augmented in the presence of hypoxia, supporting the theory of an inflammation-hypoxia cycle. This work will develop non-invasive technology for quantifying brain oxygenation, perfusion, metabolic rate and mitochondrial status in rodents. We will provide new knowledge of the inflammation-hypoxia cycle. As most PhD's do not remain in academia, I include management, communications and entrepreneurship training to ensure my HQP are poised to support Canada's knowledge based economy.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2020-05225
Name nom
Dunn, Jeffrey
Department département
Radiology - Radiology
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
80000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Regulation of brain oxygenation
Keywords
brain; oxygenation; hypoxia; inflammation; near-infrared spectroscopy; magnetic resonance imaging; mitochondrial oxidation; cerebral oxygen uptake
Application summary
My long term research program aims to determine how oxygen levels in brain are regulated, how the brain adapts to low oxygen (hypoxia) and how hypoxia impacts brain physiology and function. We developed implantable probes to quantify oxygen tension. We showed oxygen declines linearly with inspired oxygen, until a plateau is reached, corresponding to oxygen delivery limitations. We developed a near-infrared (NIRS)/MRI protocol to quantify hypoxia, perfusion and metabolic rate for oxygen (CMRO2) in rodent cortex. We showed that inflammation can cause hypoxia in the brain. As an inflammatory response is ubiquitous in vertebrates, and hypoxia is associated with impaired brain function, there must be a strong adaptive benefit of having hypoxia occur in conjunction with inflammation. This led to the current proposal. We will build on these observations and include technical developments to study the physiological and metabolic changes that occur in brain during inflammation induced hypoxia, and how hypoxia impacts the immune response in brain. In Aim 1 we will develop new NIRS processing that will allow us to extract data on cytochrome oxidase (COO), a mitochondrial enzyme key to using oxygen. We will assess different spectral regions and validate with hypoxia and a mitochondrial inhibitor. The improved capability to assess COO will allow us to quantify mitochondrial redox-a marker of mitochondrial function. In Aim 2 we will characterize the temporal and spatial pattern of inflammation related hypoxia in brain. We will combine NIRS, implanted probes, and histology to study hypoxia induced by inflammation (lipopolysaccharide). In Aim 3 we will test the hypothesis that such inflammation induced hypoxia is associated with mitochondrial impairment, reduced metabolic rate and reduced perfusion. We will quantify arterial saturation, perfusion with 9.4T MRI arterial spin labelling, microvascular hemoglobin saturation with NIRS and CMRO2. COO will be assessed with NIRS, stains for COO and mitochondrial respiration studies. We will quantify hypoxia inducible factor (HIF1-a) and a marker of inflammation (NfkB). We hypothesize that hypoxia can cause a feedback loop to further stimulate inflammation. In Aim 4 we will stimulate inflammation in the presence of acute inspired hypoxia. Animals will be exposed to ½ atmosphere hypobaric hypoxia, and inflammation will be induced by exposure to LPS. We hypothesize that inflammatory markers and physiological responses will be augmented in the presence of hypoxia, supporting the theory of an inflammation-hypoxia cycle. This work will develop non-invasive technology for quantifying brain oxygenation, perfusion, metabolic rate and mitochondrial status in rodents. We will provide new knowledge of the inflammation-hypoxia cycle. As most PhD's do not remain in academia, I include management, communications and entrepreneurship training to ensure my HQP are poised to support Canada's knowledge based economy.